However, some scholars argue that MAFLD-related lipid metabolism disorders and lipotoxicity may induce inflammation, disrupting hepatocyte homeostasis, resulting in elevated alanine aminotransferase (ALT) levels in patients with CHB, with potential progression to cirrhosis and HCC [4]. Here, GPT is linked to Disorder of lipid metabolism.